Last $4.55 USD
Change Today +0.03 / 0.66%
Volume 62.6K
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hal E. Kruth

Chief Executive Officer of Qinetiq Ventures Limited, President of Qinetiq Inc, Director of Qinetiq Plc and Director of Simedica Ltd, pSivida Corp.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 4 different organizations across 7 different industries.

See Board Relationships
----

Background*

Mr. Hal E. Kruth serves as President of QinetiQ Inc. in the US and Chief Executive Officer of QinetiQ Ventures Limited. Mr. Kruth serves as Commercial Director and Director of Qinetiq. Mr. Hal joined QinetiQ from SRI International, one of the world's leading independent research organisations where he managed major transactions involving start-up companies, licensing, sponsored research, joint ventures and technology spin-offs. He served as Group Managing Director of ...

Read Full Background

Corporate Headquarters*

400 Pleasant Street
Watertown, Massachusetts 02472

United States

Phone: 617-926-5000
Fax: 617-926-5050

Board Members Memberships*

Group Commercial Director and Director
Former Chairman of QinetiQ Ventures
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PSDV:US $4.55 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSIVIDA CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.